These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15405)

  • 21. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
    Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Ann Intern Med; 1977 Aug; 87(2):176-82. PubMed ID: 889198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic and therapeutic uses of saralasin in renal transplant hypertension.
    Zawada ET; Maxwell MH; Marks LS; Lee DB; Kaufman JJ
    J Urol; 1980 Feb; 123(2):148-52. PubMed ID: 6986475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Saralasin (1-sar-8-ala-angiotensin II): pharmacology and clinical use in angiotensin-dependent hypertension.
    Streeten DH; Castellian AW; Micalizzi ER; Dalakos TG; Anderson GH; Freiberg JM; Keenan RE
    Contrib Nephrol; 1976; 3():52-70. PubMed ID: 1026370
    [No Abstract]   [Full Text] [Related]  

  • 25. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH; Case DB; Wallace JM; Keim H
    Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of saralasin in hypertensive patients on chronic hemodialysis.
    Lifschitz MD; Kirschenbaum MA; Rosenblatt SG; Gibney R
    Ann Intern Med; 1978 Jan; 88(1):23-7. PubMed ID: 619754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The adrenal receptor for angiotensin II is altered in essential hypertension.
    Williams GH; Hollenberg NK; Moore TJ; Swartz SL; Dluhy RG
    J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ; Boyd GW; Peart WS
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin blockade in hypertension.
    Streeten DH; Anderson GH
    Ann Intern Med; 1977 Mar; 86(3):353-4. PubMed ID: 842997
    [No Abstract]   [Full Text] [Related]  

  • 30. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
    Anderson GH; Streeten DH; Dalakos TG
    Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of surgical response in renovascular hypertension using angiotensin II blockade.
    Buda JA; Baer L; Arora SP; Parra-Carrillo JZ; Radichevich I
    Surgery; 1978 Nov; 84(5):664-70. PubMed ID: 715682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Saralasin in the diagnosis of angiotensin-dependent hypertension and in the study of the renin-angiotensin-aldosterone system].
    Falch D
    Tidsskr Nor Laegeforen; 1983 Apr; 103(11):906-8. PubMed ID: 6879526
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sar,Ala]angiotensin II in cerebrospinal fluid blocks the binding of blood-borne [125I]angiotensin II to the circumventricular organs.
    Van Houten M; Mangiapane ML; Reid IA; Ganong WF
    Neuroscience; 1983 Dec; 10(4):1421-6. PubMed ID: 6320051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of saralasin on plasma renin activity and arginine-vasopressin in patients with angiotensin-dependent hypertension (author's transl)].
    Arlart IP; Wagner H; Rosenthal J
    Klin Wochenschr; 1978 Jun; 56(12):625-7. PubMed ID: 682528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologic determinants and clinical applications of angiotensin II blockade in hypertensive disorders.
    Parra-Carrillo JZ; Baer L; Radichevich I
    Cardiovasc Clin; 1978; 9(1):183-95. PubMed ID: 667880
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of the angiotensin antagonist saralasin (1-sar-8-ala-angiotensin II) on the blood pressure in secondary hypertension].
    Beckerhoff R; Vetter W; Furrer J; Tuma J; Zàruba K; Vetter H; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1738-41. PubMed ID: 1013696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of angiotensin II antagonist in advanced hypertension.
    Yasujima M; Abe K; Irokawa N; Ritsu K; Deino M
    Tohoku J Exp Med; 1977 Jun; 122(2):191-7. PubMed ID: 888141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of sar1 ala8 angiotensin II (saralasin) on plasma aldosterone in hypertensive patients.
    Donker AJ; van Hoogdalem P; Pratt JJ; Leenen FH
    Acta Med Scand; 1979; 205(3):207-12. PubMed ID: 425848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pressor response to saralasin (1-sar-8-ala-angiotensin II) bolus injection in hypertensive patients.
    Waks UA; Maxwell MH; Marks L; Zawada ET; Kaufman JJ
    Circulation; 1978 Jun; 57(6):1165-70. PubMed ID: 639240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of the saralasin test to the treatment of malignant or accelerated arterial hypertension (author's transl)].
    Bonnet F; Corvol P; Thibonnier M; Reach G; Lardoux MD; Milliez P
    Nouv Presse Med; 1980 Nov; 9(41):3075-8. PubMed ID: 7443447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.